orphan drug designations - Articles and news items


The Good, the Bad, and the Donald: what Pharma can expect from 2017

Blog, Z Homepage promo / 11 January 2017 / Niamh Marriott, Digital Editor

From an orphan drug sales boom to uncharted political landscapes, the CPhI Worldwide expert panel predict pharma’s biggest opportunities and threats in 2017.

Cancer treatment receives EU drug designations

Industry news / 20 July 2016 / Niamh Louise Marriott, Digital Content Producer

With the EU orhpan drug designations, Cell Medica can now obtain regulatory and financial incentives for developing and marketing CMD-003 as a cancer…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...